rs745578106
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001037.5(SCN1B):c.64G>A(p.Val22Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001037.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN1B | NM_001037.5 | c.64G>A | p.Val22Met | missense_variant | Exon 2 of 6 | ENST00000262631.11 | NP_001028.1 | |
| SCN1B | NM_001321605.2 | c.-36G>A | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 6 | NP_001308534.1 | |||
| SCN1B | NM_199037.5 | c.64G>A | p.Val22Met | missense_variant | Exon 2 of 3 | NP_950238.1 | ||
| SCN1B | NM_001321605.2 | c.-36G>A | 5_prime_UTR_variant | Exon 2 of 6 | NP_001308534.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152244Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250878 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461644Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727158 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Brugada syndrome 5 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 22 of the SCN1B protein (p.Val22Met). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with SCN1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 568522). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.V22M variant (also known as c.64G>A), located in coding exon 2 of the SCN1B gene, results from a G to A substitution at nucleotide position 64. The valine at codon 22 is replaced by methionine, an amino acid with highly similar properties. This variant was reported in individual(s) with features consistent with epilepsy (Truty R et al. Epilepsia Open, 2019 Sep;4:397-408; Epi25 Collaborative. Nat Neurosci, 2024 Oct;27:1864-1879). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at